GO:0005575 | cellular_component | 53.4% (55/103) | 1.42 | 0.0 | 0.0 |
GO:0043226 | organelle | 32.04% (33/103) | 1.97 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 32.04% (33/103) | 1.97 | 0.0 | 0.0 |
GO:0043227 | membrane-bounded organelle | 28.16% (29/103) | 1.99 | 0.0 | 0.0 |
GO:0043231 | intracellular membrane-bounded organelle | 28.16% (29/103) | 2.01 | 0.0 | 0.0 |
GO:0009987 | cellular process | 46.6% (48/103) | 1.34 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 44.66% (46/103) | 1.34 | 0.0 | 0.0 |
GO:0009150 | purine ribonucleotide metabolic process | 8.74% (9/103) | 4.53 | 0.0 | 0.0 |
GO:0009259 | ribonucleotide metabolic process | 8.74% (9/103) | 4.33 | 0.0 | 0.0 |
GO:0019693 | ribose phosphate metabolic process | 8.74% (9/103) | 4.27 | 0.0 | 0.0 |
GO:0006163 | purine nucleotide metabolic process | 8.74% (9/103) | 4.16 | 0.0 | 0.0 |
GO:0044281 | small molecule metabolic process | 15.53% (16/103) | 2.71 | 0.0 | 0.0 |
GO:0072521 | purine-containing compound metabolic process | 8.74% (9/103) | 4.07 | 0.0 | 0.0 |
GO:0009117 | nucleotide metabolic process | 8.74% (9/103) | 3.9 | 0.0 | 1e-06 |
GO:0006753 | nucleoside phosphate metabolic process | 8.74% (9/103) | 3.89 | 0.0 | 1e-06 |
GO:0003680 | minor groove of adenine-thymine-rich DNA binding | 3.88% (4/103) | 7.15 | 0.0 | 1e-06 |
GO:0000278 | mitotic cell cycle | 4.85% (5/103) | 5.86 | 0.0 | 1e-06 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 8.74% (9/103) | 3.68 | 0.0 | 2e-06 |
GO:0046034 | ATP metabolic process | 5.83% (6/103) | 5.0 | 0.0 | 2e-06 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 5.83% (6/103) | 4.92 | 0.0 | 2e-06 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 5.83% (6/103) | 4.9 | 0.0 | 2e-06 |
GO:0003674 | molecular_function | 61.17% (63/103) | 0.79 | 0.0 | 3e-06 |
GO:0000217 | DNA secondary structure binding | 3.88% (4/103) | 6.52 | 0.0 | 4e-06 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 5.83% (6/103) | 4.7 | 0.0 | 4e-06 |
GO:0007049 | cell cycle | 4.85% (5/103) | 5.38 | 0.0 | 5e-06 |
GO:0009141 | nucleoside triphosphate metabolic process | 5.83% (6/103) | 4.66 | 0.0 | 5e-06 |
GO:0005737 | cytoplasm | 15.53% (16/103) | 2.27 | 0.0 | 5e-06 |
GO:0008150 | biological_process | 51.46% (53/103) | 0.89 | 0.0 | 8e-06 |
GO:1901135 | carbohydrate derivative metabolic process | 8.74% (9/103) | 3.32 | 0.0 | 8e-06 |
GO:0009152 | purine ribonucleotide biosynthetic process | 4.85% (5/103) | 5.02 | 1e-06 | 1.3e-05 |
GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1) | 2.91% (3/103) | 7.44 | 1e-06 | 1.7e-05 |
GO:0030955 | potassium ion binding | 2.91% (3/103) | 7.3 | 1e-06 | 1.9e-05 |
GO:0031420 | alkali metal ion binding | 2.91% (3/103) | 7.3 | 1e-06 | 1.9e-05 |
GO:0004743 | pyruvate kinase activity | 2.91% (3/103) | 7.3 | 1e-06 | 1.9e-05 |
GO:0006099 | tricarboxylic acid cycle | 3.88% (4/103) | 5.74 | 1e-06 | 2e-05 |
GO:0032991 | protein-containing complex | 17.48% (18/103) | 1.92 | 1e-06 | 2e-05 |
GO:0005739 | mitochondrion | 7.77% (8/103) | 3.4 | 1e-06 | 2.1e-05 |
GO:0098534 | centriole assembly | 1.94% (2/103) | 10.34 | 1e-06 | 2.1e-05 |
GO:0007099 | centriole replication | 1.94% (2/103) | 10.34 | 1e-06 | 2.1e-05 |
GO:0005814 | centriole | 1.94% (2/103) | 10.34 | 1e-06 | 2.1e-05 |
GO:0098798 | mitochondrial protein-containing complex | 4.85% (5/103) | 4.74 | 1e-06 | 2.4e-05 |
GO:0015252 | proton channel activity | 2.91% (3/103) | 7.0 | 2e-06 | 3.1e-05 |
GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism | 2.91% (3/103) | 7.0 | 2e-06 | 3.1e-05 |
GO:0006164 | purine nucleotide biosynthetic process | 4.85% (5/103) | 4.66 | 2e-06 | 3.1e-05 |
GO:0019637 | organophosphate metabolic process | 8.74% (9/103) | 2.94 | 3e-06 | 4.1e-05 |
GO:0009260 | ribonucleotide biosynthetic process | 4.85% (5/103) | 4.56 | 3e-06 | 4.1e-05 |
GO:0072522 | purine-containing compound biosynthetic process | 4.85% (5/103) | 4.55 | 3e-06 | 4.1e-05 |
GO:0006082 | organic acid metabolic process | 9.71% (10/103) | 2.73 | 3e-06 | 4.2e-05 |
GO:0032787 | monocarboxylic acid metabolic process | 6.8% (7/103) | 3.51 | 3e-06 | 4.2e-05 |
GO:0046390 | ribose phosphate biosynthetic process | 4.85% (5/103) | 4.51 | 3e-06 | 4.2e-05 |
GO:0019752 | carboxylic acid metabolic process | 9.71% (10/103) | 2.74 | 3e-06 | 4.2e-05 |
GO:0043436 | oxoacid metabolic process | 9.71% (10/103) | 2.73 | 3e-06 | 4.2e-05 |
GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain | 2.91% (3/103) | 6.76 | 3e-06 | 4.2e-05 |
GO:0007017 | microtubule-based process | 5.83% (6/103) | 3.89 | 4e-06 | 4.5e-05 |
GO:0046483 | heterocycle metabolic process | 17.48% (18/103) | 1.8 | 4e-06 | 4.5e-05 |
GO:0015986 | proton motive force-driven ATP synthesis | 2.91% (3/103) | 6.7 | 4e-06 | 4.5e-05 |
GO:0006754 | ATP biosynthetic process | 2.91% (3/103) | 6.7 | 4e-06 | 4.5e-05 |
GO:0042709 | succinate-CoA ligase complex | 1.94% (2/103) | 9.34 | 4e-06 | 4.9e-05 |
GO:0004775 | succinate-CoA ligase (ADP-forming) activity | 1.94% (2/103) | 9.34 | 4e-06 | 4.9e-05 |
GO:0004774 | succinate-CoA ligase activity | 1.94% (2/103) | 9.34 | 4e-06 | 4.9e-05 |
GO:0006090 | pyruvate metabolic process | 4.85% (5/103) | 4.43 | 4e-06 | 4.9e-05 |
GO:0044237 | cellular metabolic process | 28.16% (29/103) | 1.26 | 5e-06 | 5.4e-05 |
GO:0005200 | structural constituent of cytoskeleton | 2.91% (3/103) | 6.54 | 5e-06 | 5.6e-05 |
GO:0005634 | nucleus | 14.56% (15/103) | 1.98 | 6e-06 | 6.5e-05 |
GO:0098800 | inner mitochondrial membrane protein complex | 3.88% (4/103) | 5.07 | 7e-06 | 7.3e-05 |
GO:1901360 | organic cyclic compound metabolic process | 17.48% (18/103) | 1.72 | 8e-06 | 7.9e-05 |
GO:1902494 | catalytic complex | 9.71% (10/103) | 2.57 | 8e-06 | 8.3e-05 |
GO:0034641 | cellular nitrogen compound metabolic process | 17.48% (18/103) | 1.71 | 9e-06 | 8.6e-05 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 2.91% (3/103) | 6.25 | 1e-05 | 9.1e-05 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 2.91% (3/103) | 6.25 | 1e-05 | 9.1e-05 |
GO:1901004 | ubiquinone-6 metabolic process | 1.94% (2/103) | 8.76 | 1e-05 | 9.5e-05 |
GO:1901006 | ubiquinone-6 biosynthetic process | 1.94% (2/103) | 8.76 | 1e-05 | 9.5e-05 |
GO:0009165 | nucleotide biosynthetic process | 4.85% (5/103) | 4.1 | 1.2e-05 | 0.000113 |
GO:1901293 | nucleoside phosphate biosynthetic process | 4.85% (5/103) | 4.1 | 1.2e-05 | 0.000113 |
GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) | 1.94% (2/103) | 8.47 | 1.5e-05 | 0.000137 |
GO:0008152 | metabolic process | 33.01% (34/103) | 1.04 | 1.7e-05 | 0.00015 |
GO:0016043 | cellular component organization | 11.65% (12/103) | 2.14 | 1.9e-05 | 0.000168 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 8.74% (9/103) | 2.52 | 3e-05 | 0.000259 |
GO:0031418 | L-ascorbic acid binding | 1.94% (2/103) | 7.7 | 4.5e-05 | 0.000379 |
GO:0000287 | magnesium ion binding | 3.88% (4/103) | 4.38 | 4.6e-05 | 0.000387 |
GO:1901566 | organonitrogen compound biosynthetic process | 7.77% (8/103) | 2.64 | 4.7e-05 | 0.000392 |
GO:0018208 | peptidyl-proline modification | 2.91% (3/103) | 5.47 | 4.8e-05 | 0.000393 |
GO:0043603 | amide metabolic process | 5.83% (6/103) | 3.21 | 5.2e-05 | 0.000425 |
GO:0071840 | cellular component organization or biogenesis | 11.65% (12/103) | 1.98 | 5.5e-05 | 0.00044 |
GO:0016418 | S-acetyltransferase activity | 1.94% (2/103) | 7.51 | 5.8e-05 | 0.000451 |
GO:0004742 | dihydrolipoyllysine-residue acetyltransferase activity | 1.94% (2/103) | 7.51 | 5.8e-05 | 0.000451 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 2.91% (3/103) | 5.38 | 5.7e-05 | 0.000454 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 2.91% (3/103) | 5.36 | 5.9e-05 | 0.000454 |
GO:0030060 | L-malate dehydrogenase activity | 1.94% (2/103) | 7.42 | 6.6e-05 | 0.000497 |
GO:0044249 | cellular biosynthetic process | 11.65% (12/103) | 1.95 | 6.7e-05 | 0.000501 |
GO:0006807 | nitrogen compound metabolic process | 26.21% (27/103) | 1.12 | 6.9e-05 | 0.000509 |
GO:0015078 | proton transmembrane transporter activity | 3.88% (4/103) | 4.22 | 7e-05 | 0.00051 |
GO:0019798 | procollagen-proline dioxygenase activity | 1.94% (2/103) | 7.22 | 8.7e-05 | 0.000595 |
GO:0004656 | procollagen-proline 4-dioxygenase activity | 1.94% (2/103) | 7.22 | 8.7e-05 | 0.000595 |
GO:0031545 | peptidyl-proline 4-dioxygenase activity | 1.94% (2/103) | 7.22 | 8.7e-05 | 0.000595 |
GO:0019471 | 4-hydroxyproline metabolic process | 1.94% (2/103) | 7.22 | 8.7e-05 | 0.000595 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 1.94% (2/103) | 7.22 | 8.7e-05 | 0.000595 |
GO:0044238 | primary metabolic process | 29.13% (30/103) | 1.02 | 8.9e-05 | 0.000605 |
GO:0019511 | peptidyl-proline hydroxylation | 1.94% (2/103) | 7.19 | 9.1e-05 | 0.000607 |
GO:0031543 | peptidyl-proline dioxygenase activity | 1.94% (2/103) | 7.19 | 9.1e-05 | 0.000607 |
GO:0003824 | catalytic activity | 33.98% (35/103) | 0.91 | 8.6e-05 | 0.000623 |
GO:0006139 | nucleobase-containing compound metabolic process | 14.56% (15/103) | 1.63 | 9.6e-05 | 0.000636 |
GO:1901564 | organonitrogen compound metabolic process | 20.39% (21/103) | 1.3 | 9.8e-05 | 0.000642 |
GO:0005216 | monoatomic ion channel activity | 3.88% (4/103) | 4.08 | 0.000102 | 0.000659 |
GO:0071704 | organic substance metabolic process | 30.1% (31/103) | 0.98 | 0.000109 | 0.000688 |
GO:0006637 | acyl-CoA metabolic process | 2.91% (3/103) | 5.06 | 0.000109 | 0.000694 |
GO:0035383 | thioester metabolic process | 2.91% (3/103) | 5.06 | 0.000109 | 0.000694 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4.85% (5/103) | 3.41 | 0.00012 | 0.00075 |
GO:0043604 | amide biosynthetic process | 4.85% (5/103) | 3.37 | 0.000136 | 0.00084 |
GO:0005198 | structural molecule activity | 4.85% (5/103) | 3.35 | 0.000147 | 0.000892 |
GO:0018130 | heterocycle biosynthetic process | 6.8% (7/103) | 2.63 | 0.000153 | 0.000895 |
GO:1901576 | organic substance biosynthetic process | 11.65% (12/103) | 1.83 | 0.000147 | 0.000898 |
GO:0005488 | binding | 38.83% (40/103) | 0.78 | 0.00015 | 0.000899 |
GO:0018126 | protein hydroxylation | 1.94% (2/103) | 6.82 | 0.000151 | 0.0009 |
GO:0005261 | monoatomic cation channel activity | 2.91% (3/103) | 4.9 | 0.000152 | 0.0009 |
GO:0000226 | microtubule cytoskeleton organization | 3.88% (4/103) | 3.9 | 0.000162 | 0.000941 |
GO:0045254 | pyruvate dehydrogenase complex | 1.94% (2/103) | 6.74 | 0.000169 | 0.000973 |
GO:0022607 | cellular component assembly | 5.83% (6/103) | 2.86 | 0.000199 | 0.001134 |
GO:0000325 | plant-type vacuole | 1.94% (2/103) | 6.6 | 0.000205 | 0.001159 |
GO:0045239 | tricarboxylic acid cycle enzyme complex | 1.94% (2/103) | 6.5 | 0.000237 | 0.001317 |
GO:0009058 | biosynthetic process | 11.65% (12/103) | 1.76 | 0.000236 | 0.001323 |
GO:0006725 | cellular aromatic compound metabolic process | 14.56% (15/103) | 1.5 | 0.000261 | 0.00144 |
GO:0015267 | channel activity | 3.88% (4/103) | 3.71 | 0.000273 | 0.001483 |
GO:0022803 | passive transmembrane transporter activity | 3.88% (4/103) | 3.71 | 0.000273 | 0.001483 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 5.83% (6/103) | 2.77 | 0.000277 | 0.001491 |
GO:0031023 | microtubule organizing center organization | 1.94% (2/103) | 6.36 | 0.000287 | 0.001531 |
GO:0006086 | acetyl-CoA biosynthetic process from pyruvate | 1.94% (2/103) | 6.29 | 0.000316 | 0.001672 |
GO:0034032 | purine nucleoside bisphosphate metabolic process | 2.91% (3/103) | 4.5 | 0.000338 | 0.001751 |
GO:0033875 | ribonucleoside bisphosphate metabolic process | 2.91% (3/103) | 4.5 | 0.000338 | 0.001751 |
GO:0033865 | nucleoside bisphosphate metabolic process | 2.91% (3/103) | 4.5 | 0.000338 | 0.001751 |
GO:1901362 | organic cyclic compound biosynthetic process | 6.8% (7/103) | 2.41 | 0.000385 | 0.001963 |
GO:1990204 | oxidoreductase complex | 2.91% (3/103) | 4.44 | 0.000383 | 0.001969 |
GO:0009134 | nucleoside diphosphate catabolic process | 2.91% (3/103) | 4.36 | 0.000452 | 0.002127 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 2.91% (3/103) | 4.36 | 0.000452 | 0.002127 |
GO:0007010 | cytoskeleton organization | 3.88% (4/103) | 3.51 | 0.000459 | 0.002145 |
GO:0006096 | glycolytic process | 2.91% (3/103) | 4.36 | 0.00045 | 0.00215 |
GO:0046031 | ADP metabolic process | 2.91% (3/103) | 4.36 | 0.00045 | 0.00215 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 2.91% (3/103) | 4.36 | 0.00045 | 0.00215 |
GO:0046032 | ADP catabolic process | 2.91% (3/103) | 4.36 | 0.00045 | 0.00215 |
GO:0009135 | purine nucleoside diphosphate metabolic process | 2.91% (3/103) | 4.36 | 0.00045 | 0.00215 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 2.91% (3/103) | 4.36 | 0.00045 | 0.00215 |
GO:0009137 | purine nucleoside diphosphate catabolic process | 2.91% (3/103) | 4.36 | 0.00045 | 0.00215 |
GO:0019364 | pyridine nucleotide catabolic process | 2.91% (3/103) | 4.35 | 0.000464 | 0.002155 |
GO:0072526 | pyridine-containing compound catabolic process | 2.91% (3/103) | 4.33 | 0.000479 | 0.002206 |
GO:0008353 | RNA polymerase II CTD heptapeptide repeat kinase activity | 1.94% (2/103) | 6.05 | 0.000439 | 0.002223 |
GO:0006790 | sulfur compound metabolic process | 3.88% (4/103) | 3.48 | 0.000487 | 0.00223 |
GO:0090407 | organophosphate biosynthetic process | 4.85% (5/103) | 2.99 | 0.000447 | 0.002244 |
GO:0003906 | DNA-(apurinic or apyrimidinic site) endonuclease activity | 1.94% (2/103) | 5.95 | 0.000506 | 0.002302 |
GO:0009261 | ribonucleotide catabolic process | 2.91% (3/103) | 4.27 | 0.000543 | 0.002438 |
GO:0009154 | purine ribonucleotide catabolic process | 2.91% (3/103) | 4.27 | 0.000542 | 0.002446 |
GO:0005525 | GTP binding | 3.88% (4/103) | 3.42 | 0.000567 | 0.002511 |
GO:0032561 | guanyl ribonucleotide binding | 3.88% (4/103) | 3.42 | 0.000567 | 0.002511 |
GO:0006195 | purine nucleotide catabolic process | 2.91% (3/103) | 4.23 | 0.000582 | 0.002561 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 2.91% (3/103) | 4.23 | 0.000589 | 0.002576 |
GO:0009132 | nucleoside diphosphate metabolic process | 2.91% (3/103) | 4.22 | 0.000599 | 0.002599 |
GO:0009166 | nucleotide catabolic process | 2.91% (3/103) | 4.21 | 0.000608 | 0.002606 |
GO:0048029 | monosaccharide binding | 1.94% (2/103) | 5.82 | 0.000606 | 0.002615 |
GO:0016874 | ligase activity | 4.85% (5/103) | 2.89 | 0.000621 | 0.002647 |
GO:0019001 | guanyl nucleotide binding | 3.88% (4/103) | 3.38 | 0.000634 | 0.002683 |
GO:1901292 | nucleoside phosphate catabolic process | 2.91% (3/103) | 4.18 | 0.000644 | 0.002708 |
GO:0032968 | positive regulation of transcription elongation by RNA polymerase II | 1.94% (2/103) | 5.75 | 0.000666 | 0.002782 |
GO:0044272 | sulfur compound biosynthetic process | 2.91% (3/103) | 4.15 | 0.000693 | 0.002811 |
GO:0006091 | generation of precursor metabolites and energy | 3.88% (4/103) | 3.34 | 0.000698 | 0.002813 |
GO:0006743 | ubiquinone metabolic process | 1.94% (2/103) | 5.72 | 0.00069 | 0.002815 |
GO:0006744 | ubiquinone biosynthetic process | 1.94% (2/103) | 5.72 | 0.00069 | 0.002815 |
GO:0009361 | succinate-CoA ligase complex (ADP-forming) | 0.97% (1/103) | 10.51 | 0.000685 | 0.00283 |
GO:0004776 | succinate-CoA ligase (GDP-forming) activity | 0.97% (1/103) | 10.51 | 0.000685 | 0.00283 |
GO:0034243 | regulation of transcription elongation by RNA polymerase II | 1.94% (2/103) | 5.7 | 0.000715 | 0.002865 |
GO:0016417 | S-acyltransferase activity | 1.94% (2/103) | 5.65 | 0.00076 | 0.003026 |
GO:0072523 | purine-containing compound catabolic process | 2.91% (3/103) | 4.07 | 0.000808 | 0.00318 |
GO:0016615 | malate dehydrogenase activity | 1.94% (2/103) | 5.61 | 0.000806 | 0.00319 |
GO:0019842 | vitamin binding | 2.91% (3/103) | 4.06 | 0.000819 | 0.003205 |
GO:0098796 | membrane protein complex | 4.85% (5/103) | 2.8 | 0.000826 | 0.003214 |
GO:0006085 | acetyl-CoA biosynthetic process | 1.94% (2/103) | 5.56 | 0.000867 | 0.003353 |
GO:0035384 | thioester biosynthetic process | 1.94% (2/103) | 5.5 | 0.00093 | 0.003557 |
GO:0071616 | acyl-CoA biosynthetic process | 1.94% (2/103) | 5.5 | 0.00093 | 0.003557 |
GO:0070816 | obsolete phosphorylation of RNA polymerase II C-terminal domain | 1.94% (2/103) | 5.49 | 0.000944 | 0.003591 |
GO:0005874 | microtubule | 2.91% (3/103) | 3.97 | 0.000991 | 0.003748 |
GO:0019104 | DNA N-glycosylase activity | 1.94% (2/103) | 5.41 | 0.001056 | 0.003968 |
GO:0003676 | nucleic acid binding | 15.53% (16/103) | 1.24 | 0.001129 | 0.00422 |
GO:0140994 | RNA polymerase II CTD heptapeptide repeat modifying activity | 1.94% (2/103) | 5.33 | 0.001189 | 0.004419 |
GO:0099512 | supramolecular fiber | 2.91% (3/103) | 3.84 | 0.001278 | 0.004624 |
GO:0099081 | supramolecular polymer | 2.91% (3/103) | 3.84 | 0.001278 | 0.004624 |
GO:0046872 | metal ion binding | 9.71% (10/103) | 1.67 | 0.001258 | 0.004652 |
GO:0015075 | monoatomic ion transmembrane transporter activity | 4.85% (5/103) | 2.65 | 0.001275 | 0.004662 |
GO:0099513 | polymeric cytoskeletal fiber | 2.91% (3/103) | 3.84 | 0.001269 | 0.004667 |
GO:0019438 | aromatic compound biosynthetic process | 5.83% (6/103) | 2.33 | 0.001312 | 0.004695 |
GO:1901136 | carbohydrate derivative catabolic process | 2.91% (3/103) | 3.83 | 0.001308 | 0.004707 |
GO:0006084 | acetyl-CoA metabolic process | 1.94% (2/103) | 5.15 | 0.001513 | 0.005389 |
GO:0004842 | ubiquitin-protein transferase activity | 3.88% (4/103) | 3.03 | 0.001534 | 0.005404 |
GO:0043169 | cation binding | 9.71% (10/103) | 1.63 | 0.00153 | 0.005421 |
GO:0016878 | acid-thiol ligase activity | 1.94% (2/103) | 5.12 | 0.001577 | 0.005529 |
GO:0032786 | positive regulation of DNA-templated transcription, elongation | 1.94% (2/103) | 5.08 | 0.001661 | 0.005764 |
GO:0016746 | acyltransferase activity | 5.83% (6/103) | 2.27 | 0.001653 | 0.005764 |
GO:0006284 | base-excision repair | 1.94% (2/103) | 5.08 | 0.001671 | 0.005767 |
GO:0019787 | ubiquitin-like protein transferase activity | 3.88% (4/103) | 2.98 | 0.001742 | 0.005982 |
GO:1901663 | quinone biosynthetic process | 1.94% (2/103) | 5.03 | 0.001787 | 0.006042 |
GO:1901661 | quinone metabolic process | 1.94% (2/103) | 5.03 | 0.001787 | 0.006042 |
GO:0042181 | ketone biosynthetic process | 1.94% (2/103) | 5.03 | 0.001787 | 0.006042 |
GO:0031406 | carboxylic acid binding | 1.94% (2/103) | 5.02 | 0.001806 | 0.006048 |
GO:0043177 | organic acid binding | 1.94% (2/103) | 5.02 | 0.001806 | 0.006048 |
GO:0016755 | aminoacyltransferase activity | 3.88% (4/103) | 2.95 | 0.001894 | 0.00631 |
GO:0046434 | organophosphate catabolic process | 2.91% (3/103) | 3.62 | 0.001968 | 0.006526 |
GO:0034033 | purine nucleoside bisphosphate biosynthetic process | 1.94% (2/103) | 4.94 | 0.001998 | 0.006527 |
GO:0033866 | nucleoside bisphosphate biosynthetic process | 1.94% (2/103) | 4.94 | 0.001998 | 0.006527 |
GO:0034030 | ribonucleoside bisphosphate biosynthetic process | 1.94% (2/103) | 4.94 | 0.001998 | 0.006527 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 0.97% (1/103) | 8.93 | 0.002055 | 0.006617 |
GO:0017062 | respiratory chain complex III assembly | 0.97% (1/103) | 8.93 | 0.002055 | 0.006617 |
GO:0019362 | pyridine nucleotide metabolic process | 2.91% (3/103) | 3.59 | 0.002068 | 0.006626 |
GO:0046496 | nicotinamide nucleotide metabolic process | 2.91% (3/103) | 3.6 | 0.002044 | 0.006644 |
GO:0006796 | phosphate-containing compound metabolic process | 11.65% (12/103) | 1.38 | 0.002265 | 0.007226 |
GO:0072524 | pyridine-containing compound metabolic process | 2.91% (3/103) | 3.53 | 0.002362 | 0.007497 |
GO:0006793 | phosphorus metabolic process | 11.65% (12/103) | 1.37 | 0.002375 | 0.007504 |
GO:0006104 | succinyl-CoA metabolic process | 0.97% (1/103) | 8.7 | 0.002397 | 0.007538 |
GO:0005813 | centrosome | 1.94% (2/103) | 4.81 | 0.002409 | 0.007541 |
GO:0065003 | protein-containing complex assembly | 3.88% (4/103) | 2.84 | 0.002469 | 0.007657 |
GO:0032784 | regulation of DNA-templated transcription elongation | 1.94% (2/103) | 4.79 | 0.002466 | 0.007683 |
GO:0097159 | organic cyclic compound binding | 25.24% (26/103) | 0.81 | 0.002492 | 0.007693 |
GO:0043933 | protein-containing complex organization | 4.85% (5/103) | 2.43 | 0.002506 | 0.007701 |
GO:0061630 | ubiquitin protein ligase activity | 2.91% (3/103) | 3.47 | 0.002619 | 0.008013 |
GO:0061659 | ubiquitin-like protein ligase activity | 2.91% (3/103) | 3.41 | 0.002954 | 0.008995 |
GO:0022890 | inorganic cation transmembrane transporter activity | 3.88% (4/103) | 2.76 | 0.003061 | 0.00928 |
GO:0005815 | microtubule organizing center | 1.94% (2/103) | 4.62 | 0.003081 | 0.009299 |
GO:0042180 | cellular ketone metabolic process | 1.94% (2/103) | 4.56 | 0.00338 | 0.010154 |
GO:0003684 | damaged DNA binding | 1.94% (2/103) | 4.54 | 0.003433 | 0.010178 |
GO:0000274 | mitochondrial proton-transporting ATP synthase, stator stalk | 0.97% (1/103) | 8.19 | 0.003422 | 0.010192 |
GO:0045265 | proton-transporting ATP synthase, stator stalk | 0.97% (1/103) | 8.19 | 0.003422 | 0.010192 |
GO:0006575 | cellular modified amino acid metabolic process | 1.94% (2/103) | 4.52 | 0.003554 | 0.010445 |
GO:0006996 | organelle organization | 5.83% (6/103) | 2.04 | 0.003539 | 0.010447 |
GO:0006457 | protein folding | 2.91% (3/103) | 3.29 | 0.003716 | 0.010872 |
GO:1990726 | Lsm1-7-Pat1 complex | 0.97% (1/103) | 8.05 | 0.003764 | 0.010966 |
GO:0000307 | cyclin-dependent protein kinase holoenzyme complex | 1.94% (2/103) | 4.45 | 0.003887 | 0.011276 |
GO:0004449 | isocitrate dehydrogenase (NAD+) activity | 0.97% (1/103) | 7.99 | 0.003935 | 0.011366 |
GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity | 0.97% (1/103) | 7.87 | 0.004276 | 0.012247 |
GO:0030291 | protein serine/threonine kinase inhibitor activity | 0.97% (1/103) | 7.87 | 0.004276 | 0.012247 |
GO:0008324 | monoatomic cation transmembrane transporter activity | 3.88% (4/103) | 2.61 | 0.004349 | 0.012403 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 0.97% (1/103) | 7.81 | 0.004447 | 0.012575 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 0.97% (1/103) | 7.81 | 0.004447 | 0.012575 |
GO:0016052 | carbohydrate catabolic process | 2.91% (3/103) | 3.15 | 0.004862 | 0.01369 |
GO:0003743 | translation initiation factor activity | 1.94% (2/103) | 4.25 | 0.005081 | 0.014249 |
GO:0016706 | 2-oxoglutarate-dependent dioxygenase activity | 1.94% (2/103) | 4.24 | 0.005146 | 0.01431 |
GO:0005688 | U6 snRNP | 0.97% (1/103) | 7.6 | 0.005129 | 0.014324 |
GO:0042776 | proton motive force-driven mitochondrial ATP synthesis | 0.97% (1/103) | 7.56 | 0.0053 | 0.014678 |
GO:0099080 | supramolecular complex | 2.91% (3/103) | 3.11 | 0.005324 | 0.014685 |
GO:0004860 | protein kinase inhibitor activity | 0.97% (1/103) | 7.47 | 0.005641 | 0.015495 |
GO:0003924 | GTPase activity | 2.91% (3/103) | 3.07 | 0.005692 | 0.015571 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 0.97% (1/103) | 7.42 | 0.005811 | 0.015834 |
GO:0015318 | inorganic molecular entity transmembrane transporter activity | 3.88% (4/103) | 2.45 | 0.006407 | 0.017386 |
GO:0009299 | mRNA transcription | 0.97% (1/103) | 7.19 | 0.006833 | 0.018469 |
GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds | 1.94% (2/103) | 4.01 | 0.007025 | 0.018762 |
GO:1904030 | negative regulation of cyclin-dependent protein kinase activity | 0.97% (1/103) | 7.15 | 0.007004 | 0.018779 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 0.97% (1/103) | 7.15 | 0.007004 | 0.018779 |
GO:0140694 | non-membrane-bounded organelle assembly | 1.94% (2/103) | 4.0 | 0.0071 | 0.018887 |
GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) | 0.97% (1/103) | 7.08 | 0.007344 | 0.019307 |
GO:0045283 | fumarate reductase complex | 0.97% (1/103) | 7.08 | 0.007344 | 0.019307 |
GO:0045257 | succinate dehydrogenase complex (ubiquinone) | 0.97% (1/103) | 7.08 | 0.007344 | 0.019307 |
GO:0045281 | succinate dehydrogenase complex | 0.97% (1/103) | 7.05 | 0.007514 | 0.019601 |
GO:0070071 | proton-transporting two-sector ATPase complex assembly | 0.97% (1/103) | 7.05 | 0.007514 | 0.019601 |
GO:0016272 | prefoldin complex | 0.97% (1/103) | 7.02 | 0.007684 | 0.019967 |
GO:1902387 | ceramide 1-phosphate binding | 0.97% (1/103) | 6.93 | 0.008195 | 0.020655 |
GO:0046625 | sphingolipid binding | 0.97% (1/103) | 6.93 | 0.008195 | 0.020655 |
GO:0097001 | ceramide binding | 0.97% (1/103) | 6.93 | 0.008195 | 0.020655 |
GO:0120017 | ceramide transfer activity | 0.97% (1/103) | 6.93 | 0.008195 | 0.020655 |
GO:0046624 | sphingolipid transporter activity | 0.97% (1/103) | 6.93 | 0.008195 | 0.020655 |
GO:0035627 | ceramide transport | 0.97% (1/103) | 6.93 | 0.008195 | 0.020655 |
GO:1902388 | ceramide 1-phosphate transfer activity | 0.97% (1/103) | 6.93 | 0.008195 | 0.020655 |
GO:0120016 | sphingolipid transfer activity | 0.97% (1/103) | 6.93 | 0.008195 | 0.020655 |
GO:1901565 | organonitrogen compound catabolic process | 3.88% (4/103) | 2.34 | 0.008429 | 0.021009 |
GO:0044283 | small molecule biosynthetic process | 3.88% (4/103) | 2.34 | 0.008422 | 0.021071 |
GO:1902554 | serine/threonine protein kinase complex | 1.94% (2/103) | 3.88 | 0.008405 | 0.021107 |
GO:0034655 | nucleobase-containing compound catabolic process | 2.91% (3/103) | 2.85 | 0.008573 | 0.021291 |
GO:0043167 | ion binding | 18.45% (19/103) | 0.84 | 0.008606 | 0.021293 |
GO:1902911 | protein kinase complex | 1.94% (2/103) | 3.85 | 0.008752 | 0.021576 |
GO:1901575 | organic substance catabolic process | 5.83% (6/103) | 1.76 | 0.009086 | 0.022316 |
GO:0120009 | intermembrane lipid transfer | 0.97% (1/103) | 6.76 | 0.009214 | 0.02255 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.91% (3/103) | 2.79 | 0.009716 | 0.023691 |
GO:0019210 | kinase inhibitor activity | 0.97% (1/103) | 6.65 | 0.009893 | 0.024037 |
GO:0016877 | ligase activity, forming carbon-sulfur bonds | 1.94% (2/103) | 3.75 | 0.009962 | 0.024116 |
GO:0016471 | vacuolar proton-transporting V-type ATPase complex | 0.97% (1/103) | 6.63 | 0.010063 | 0.024187 |
GO:0034450 | ubiquitin-ubiquitin ligase activity | 0.97% (1/103) | 6.63 | 0.010063 | 0.024187 |
GO:0070181 | small ribosomal subunit rRNA binding | 0.97% (1/103) | 6.58 | 0.010402 | 0.024914 |
GO:0000314 | organellar small ribosomal subunit | 0.97% (1/103) | 6.56 | 0.010572 | 0.025141 |
GO:0005763 | mitochondrial small ribosomal subunit | 0.97% (1/103) | 6.56 | 0.010572 | 0.025141 |
GO:0046700 | heterocycle catabolic process | 2.91% (3/103) | 2.73 | 0.010822 | 0.025556 |
GO:0044270 | cellular nitrogen compound catabolic process | 2.91% (3/103) | 2.73 | 0.010822 | 0.025556 |
GO:0033176 | proton-transporting V-type ATPase complex | 0.97% (1/103) | 6.49 | 0.011081 | 0.026075 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 0.97% (1/103) | 6.44 | 0.01142 | 0.026593 |
GO:0003677 | DNA binding | 7.77% (8/103) | 1.4 | 0.011342 | 0.026597 |
GO:0009056 | catabolic process | 5.83% (6/103) | 1.68 | 0.011406 | 0.026655 |
GO:0006102 | isocitrate metabolic process | 0.97% (1/103) | 6.42 | 0.011589 | 0.026803 |
GO:0004448 | isocitrate dehydrogenase [NAD(P)+] activity | 0.97% (1/103) | 6.42 | 0.011589 | 0.026803 |
GO:0033179 | proton-transporting V-type ATPase, V0 domain | 0.97% (1/103) | 6.4 | 0.011759 | 0.027101 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.91% (3/103) | 2.68 | 0.011836 | 0.027187 |
GO:0016297 | acyl-[acyl-carrier-protein] hydrolase activity | 0.97% (1/103) | 6.38 | 0.011928 | 0.027305 |
GO:0090079 | translation regulator activity, nucleic acid binding | 1.94% (2/103) | 3.59 | 0.01218 | 0.027693 |
GO:0008135 | translation factor activity, RNA binding | 1.94% (2/103) | 3.59 | 0.01218 | 0.027693 |
GO:1902652 | secondary alcohol metabolic process | 0.97% (1/103) | 6.34 | 0.012267 | 0.027796 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 2.91% (3/103) | 2.65 | 0.012446 | 0.027921 |
GO:0051131 | chaperone-mediated protein complex assembly | 0.97% (1/103) | 6.32 | 0.012436 | 0.027992 |
GO:0005783 | endoplasmic reticulum | 2.91% (3/103) | 2.65 | 0.012434 | 0.028081 |
GO:0033673 | negative regulation of kinase activity | 0.97% (1/103) | 6.28 | 0.012775 | 0.028188 |
GO:0006469 | negative regulation of protein kinase activity | 0.97% (1/103) | 6.28 | 0.012775 | 0.028188 |
GO:0042326 | negative regulation of phosphorylation | 0.97% (1/103) | 6.28 | 0.012775 | 0.028188 |
GO:0001933 | negative regulation of protein phosphorylation | 0.97% (1/103) | 6.28 | 0.012775 | 0.028188 |
GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m | 0.97% (1/103) | 6.28 | 0.012775 | 0.028188 |
GO:0018193 | peptidyl-amino acid modification | 2.91% (3/103) | 2.62 | 0.01332 | 0.029295 |
GO:0140096 | catalytic activity, acting on a protein | 11.65% (12/103) | 1.05 | 0.013377 | 0.029324 |
GO:0072330 | monocarboxylic acid biosynthetic process | 1.94% (2/103) | 3.5 | 0.013725 | 0.02999 |
GO:0070925 | organelle assembly | 1.94% (2/103) | 3.49 | 0.014054 | 0.03061 |
GO:0019439 | aromatic compound catabolic process | 2.91% (3/103) | 2.56 | 0.014813 | 0.032158 |
GO:0140414 | phosphopantetheine-dependent carrier activity | 0.97% (1/103) | 6.03 | 0.015141 | 0.032453 |
GO:0044620 | ACP phosphopantetheine attachment site binding | 0.97% (1/103) | 6.03 | 0.015141 | 0.032453 |
GO:0000036 | acyl carrier activity | 0.97% (1/103) | 6.03 | 0.015141 | 0.032453 |
GO:0051192 | prosthetic group binding | 0.97% (1/103) | 6.03 | 0.015141 | 0.032453 |
GO:0019941 | modification-dependent protein catabolic process | 2.91% (3/103) | 2.54 | 0.015224 | 0.032526 |
GO:0043248 | proteasome assembly | 0.97% (1/103) | 6.02 | 0.01531 | 0.032607 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 1.94% (2/103) | 3.41 | 0.01543 | 0.032656 |
GO:0045182 | translation regulator activity | 1.94% (2/103) | 3.41 | 0.015404 | 0.032703 |
GO:1901361 | organic cyclic compound catabolic process | 2.91% (3/103) | 2.53 | 0.015506 | 0.032713 |
GO:0098656 | monoatomic anion transmembrane transport | 0.97% (1/103) | 5.9 | 0.01666 | 0.035037 |
GO:0016469 | proton-transporting two-sector ATPase complex | 0.97% (1/103) | 5.87 | 0.016997 | 0.035525 |
GO:0043632 | modification-dependent macromolecule catabolic process | 2.91% (3/103) | 2.48 | 0.016974 | 0.035587 |
GO:0051213 | dioxygenase activity | 1.94% (2/103) | 3.32 | 0.017416 | 0.036289 |
GO:0045936 | negative regulation of phosphate metabolic process | 0.97% (1/103) | 5.8 | 0.017839 | 0.036941 |
GO:0010563 | negative regulation of phosphorus metabolic process | 0.97% (1/103) | 5.8 | 0.017839 | 0.036941 |
GO:0005773 | vacuole | 1.94% (2/103) | 3.3 | 0.01795 | 0.036943 |
GO:0000398 | mRNA splicing, via spliceosome | 1.94% (2/103) | 3.3 | 0.017922 | 0.036998 |
GO:0051452 | intracellular pH reduction | 0.97% (1/103) | 5.73 | 0.018681 | 0.038213 |
GO:0007035 | vacuolar acidification | 0.97% (1/103) | 5.73 | 0.018681 | 0.038213 |
GO:0006768 | biotin metabolic process | 0.97% (1/103) | 5.69 | 0.019185 | 0.039008 |
GO:0009102 | biotin biosynthetic process | 0.97% (1/103) | 5.69 | 0.019185 | 0.039008 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.94% (2/103) | 3.22 | 0.019828 | 0.040194 |
GO:0030688 | preribosome, small subunit precursor | 0.97% (1/103) | 5.63 | 0.020026 | 0.040473 |
GO:0120014 | phospholipid transfer activity | 0.97% (1/103) | 5.62 | 0.020194 | 0.04069 |
GO:0016407 | acetyltransferase activity | 1.94% (2/103) | 3.18 | 0.020902 | 0.041991 |
GO:0120013 | lipid transfer activity | 0.97% (1/103) | 5.54 | 0.021201 | 0.042465 |
GO:0031369 | translation initiation factor binding | 0.97% (1/103) | 5.53 | 0.021369 | 0.042674 |
GO:0016071 | mRNA metabolic process | 2.91% (3/103) | 2.33 | 0.022176 | 0.044154 |
GO:0000375 | RNA splicing, via transesterification reactions | 1.94% (2/103) | 3.11 | 0.022964 | 0.045589 |
GO:0051879 | Hsp90 protein binding | 0.97% (1/103) | 5.37 | 0.023883 | 0.047273 |
GO:0051348 | negative regulation of transferase activity | 0.97% (1/103) | 5.34 | 0.024384 | 0.048126 |
GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain | 0.97% (1/103) | 5.33 | 0.024552 | 0.048314 |
GO:0017022 | myosin binding | 0.97% (1/103) | 5.31 | 0.024886 | 0.048829 |